Cellectar Biosciences Total Assets 2006-2019 | CLRB

Cellectar Biosciences total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Cellectar Biosciences Annual Total Assets
(Millions of US $)
2018 $15
2017 $13
2016 $15
2015 $8
2014 $13
2013 $7
2012 $11
2011 $11
2010 $5
2009 $9
2008 $1
2007 $11
2006 $12
2005 $5
Cellectar Biosciences Quarterly Total Assets
(Millions of US $)
Q3 2019 $16
Q2 2019 $19
Q1 2019 $13
Q4 2018 $15
Q3 2018 $20
Q2 2018 $7
Q1 2018 $10
Q4 2017 $13
Q3 2017 $10
Q2 2017 $13
Q1 2017 $15
Q4 2016 $15
Q3 2016 $9
Q2 2016 $11
Q1 2016 $6
Q4 2015 $8
Q3 2015 $6
Q2 2015 $9
Q1 2015 $11
Q4 2014 $13
Q3 2014 $16
Q2 2014 $6
Q1 2014 $8
Q4 2013 $7
Q3 2013 $10
Q2 2013 $12
Q1 2013 $14
Q4 2012 $11
Q3 2012 $10
Q2 2012 $12
Q1 2012 $9
Q4 2011 $11
Q3 2011 $7
Q2 2011 $8
Q1 2011 $1
Q4 2010 $5
Q3 2010 $3
Q2 2010 $4
Q1 2010 $6
Q4 2009 $9
Q3 2009 $6
Q2 2009 $5
Q1 2009 $7
Q4 2008 $1
Q3 2008 $4
Q2 2008 $6
Q1 2008 $7
Q4 2007 $11
Q3 2007 $16
Q2 2007 $21
Q1 2007 $10
Q4 2006 $12
Q3 2006 $14
Q2 2006 $17
Q1 2006 $18
Q4 2005 $5
Q3 2005 $6
Q2 2005 $2
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.020B $0.000B
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $152.706B 27.85
Medtronic (MDT) Ireland $152.160B 21.02
Stryker (SYK) United States $75.917B 25.53
Boston Scientific (BSX) United States $62.848B 29.66
Baxter (BAX) United States $42.866B 25.99
Essilor Luxottica (ESLOY) France $34.245B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.456B 19.11
Terumo (TRUMY) Japan $27.092B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.394B 0.00
Coloplast (CLPBY) Denmark $24.797B 38.27
ResMed (RMD) United States $22.090B 40.75
Smith & Nephew SNATS (SNN) United Kingdom $20.228B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Insulet (PODD) United States $10.859B 516.62
Bio-Rad Laboratories (BIO) United States $10.615B 50.95
William Demant Holdings (WILYY) Denmark $7.675B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
Perrigo (PRGO) Ireland $7.340B 13.69
Hill-Rom Holdings (HRC) United States $7.289B 21.49
Canopy Growth (CGC) Canada $7.208B 0.00
Haemonetics (HAE) United States $5.904B 39.89
Shandong Weigao Medical Polymer (SHWGF) China $5.472B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.947B 31.08
ICU Medical (ICUI) United States $3.686B 24.03
Neogen (NEOG) United States $3.583B 59.96
GW Pharmaceuticals (GWPH) United Kingdom $3.293B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.073B 0.00
Quidel (QDEL) United States $2.950B 27.99
Aurora Cannabis (ACB) Canada $2.865B 0.00
Agios Pharmaceuticals (AGIO) United States $2.750B 0.00
National Vision Holdings (EYE) United States $2.495B 56.30
Cardiovascular Systems (CSII) United States $1.607B 0.00
Aphria (APHA) $1.384B 0.00
InMode (INMD) Israel $1.242B 0.00
AtriCure (ATRC) United States $1.206B 0.00
VAREX IMAGING (VREX) United States $1.199B 24.01
TG Therapeutics (TGTX) United States $1.006B 0.00
Phibro Animal Health (PAHC) United States $0.969B 18.14
NanoString Technologies (NSTG) United States $0.912B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.820B 31.41
Lantheus Holdings (LNTH) United States $0.795B 19.86
LeMaitre Vascular (LMAT) United States $0.711B 39.98
PetIQ (PETQ) United States $0.695B 16.96
Quanterix (QTRX) United States $0.676B 0.00
Omeros (OMER) United States $0.667B 0.00
HEXO (HEXO) $0.576B 0.00
Cerus (CERS) United States $0.560B 0.00
Surmodics (SRDX) United States $0.552B 57.38
MacroGenics (MGNX) United States $0.518B 0.00
OraSure Technologies (OSUR) United States $0.497B 29.80
Meridian Bioscience (VIVO) United States $0.413B 14.21
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.68
Owens & Minor (OMI) United States $0.346B 12.81
BioLife Solutions (BLFS) United States $0.320B 130.58
Zynex (ZYXI) United States $0.305B 34.48
Bovie Medical (APYX) United States $0.276B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.274B 0.00
United Health Products (UEEC) United States $0.251B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Viemed Healthcare (VMD) United States $0.238B 25.08
Repro-Med Systems (KRMD) United States $0.228B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.172B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Female Health (VERU) United States $0.157B 0.00
Rockwell Medical (RMTI) United States $0.142B 0.00
Cytosorbents (CTSO) United States $0.136B 0.00
Fonar (FONR) United States $0.130B 9.18
MTech Acquisition (KERN) United States $0.128B 0.00
Chimerix (CMRX) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
United-Guardian (UG) United States $0.091B 22.93
Chembio Diagnostics (CEMI) United States $0.078B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.062B 0.00
Surface Oncology (SURF) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00